2 Researchers believe this correlates with why the signs of aging start showing up in the skin and hair
Tirzepatide dual GIP/GLP-1 mechanism produces greater average weight loss (22.5% vs 15% to 17% for semaglutide in comparable trials) but also tends to cause more gastrointestinal side effects, particularly at higher doses
The SUSTAIN and LEADER trials also documented improvements in markers associated with atherosclerotic inflammation
Ozempic for Type 2 diabetes In my experience, Medicaid patients are much more likely to get coverage for Ozempic when its being prescribed for Type 2 diabetes rather than weight loss alone, says Fernando Ovalle Jr., MD, an obesity medicine specialist and contributor to Drugwatch.com
Interrupting body-checking and avoidance behaviors Weighing multiple times per day, mirror checking, pinching skin, or avoiding mirrors altogether are signs of anxiety